- Home
- IVDA vs OGEN Comparison
IVDA vs OGEN Comparison
Compare IVDA & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- OGEN
- Stock Information
- Founded
- IVDA 2003
- OGEN 1996
- Country
- IVDA United States
- OGEN United States
- Employees
- IVDA N/A
- OGEN 5
- Industry
- IVDA Computer Software: Prepackaged Software
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- OGEN Health Care
- Exchange
- IVDA Nasdaq
- OGEN Nasdaq
- Market Cap
- IVDA 6.7M
- OGEN 2.5M
- IPO Year
- IVDA N/A
- OGEN N/A
- Fundamental
- Price
- IVDA $2.11
- OGEN $1.44
- Analyst Decision
- IVDA
- OGEN
- Analyst Count
- IVDA 0
- OGEN 0
- Target Price
- IVDA N/A
- OGEN N/A
- AVG Volume (30 Days)
- IVDA 115.1K
- OGEN 981.4K
- Earning Date
- IVDA 08-13-2025
- OGEN 08-08-2025
- Dividend Yield
- IVDA N/A
- OGEN N/A
- EPS Growth
- IVDA N/A
- OGEN N/A
- EPS
- IVDA N/A
- OGEN N/A
- Revenue
- IVDA $7,148,449.00
- OGEN N/A
- Revenue This Year
- IVDA $340.48
- OGEN N/A
- Revenue Next Year
- IVDA N/A
- OGEN N/A
- P/E Ratio
- IVDA N/A
- OGEN N/A
- Revenue Growth
- IVDA 54.15
- OGEN N/A
- 52 Week Low
- IVDA $1.27
- OGEN $1.35
- 52 Week High
- IVDA $8.05
- OGEN $75.60
- Technical
- Relative Strength Index (RSI)
- IVDA 52.44
- OGEN 26.10
- Support Level
- IVDA $1.76
- OGEN $3.41
- Resistance Level
- IVDA $2.09
- OGEN $4.19
- Average True Range (ATR)
- IVDA 0.17
- OGEN 0.45
- MACD
- IVDA 0.02
- OGEN -0.19
- Stochastic Oscillator
- IVDA 81.63
- OGEN 2.55
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.